Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xerion Advanced Battery Corp (XABC) is a materials science and battery technology company that develops high-performance lithium-ion batteries using proprietary nanostructured electrode architectures. The company's core technologies, DirectPlate™ and StructurePore™, enable ultra-fast charging, high energy density, and significantly reduced manufacturing costs by simplifying the refinement and electrode production processes into a single step. While primarily serving the defense, automotive, and consumer electronics sectors, Xerion's high-power battery systems are also applicable to advanced medical devices, surgical tools, and wearables. Headquartered in Ohio, the company is scaling its domestic manufacturing capabilities to provide a sustainable and resilient supply chain for critical minerals like cobalt. Xerion is a spin-off from the University of Illinois and has received significant support from the U.S. Department of Defense and the Department of Energy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xerion Advanced Battery.